Archives
Opinion | Controlling the control arm in metastatic castration-resistant prostate cancer trials: best standard of care or the minimum standard of care?
23 Feb, 2022 | 10:03h | UTC
Systematic Review: Weekly versus tri‐weekly paclitaxel with carboplatin for first‐line treatment in women with epithelial ovarian cancer.
23 Feb, 2022 | 10:05h | UTC
M-A: Diagnostic accuracy of point-of-care tests in acute community-acquired lower respiratory tract infections.
23 Feb, 2022 | 10:07h | UTC
Review: Pruritus in pregnancy.
23 Feb, 2022 | 09:59h | UTCPruritus in Pregnancy – American Journal of Clinical Dermatology
Diagnostic test interpretation: hypernatremia.
23 Feb, 2022 | 10:02h | UTCHypernatremia – JAMA (free for a limited period)
Clinical management of chronic kidney disease-associated pruritus: current treatment options and future approaches.
23 Feb, 2022 | 10:01h | UTC
A Review of existing therapies for Actinic Keratosis: current status and future directions.
23 Feb, 2022 | 09:58h | UTC
Leukonychia: What can white nails tell us?
23 Feb, 2022 | 09:57h | UTCLeukonychia: What Can White Nails Tell Us? – American Journal of Clinical Dermatology
AGA clinical practice update on de-prescribing of proton pump inhibitors.
22 Feb, 2022 | 10:12h | UTCRelated:
Deprescribing proton pump inhibitors guideline
Review: Deprescribing Proton Pump Inhibitors
RCT: Full endoscopic discectomy non-inferior to open discectomy in patients with sciatica.
22 Feb, 2022 | 10:11h | UTC
Meta-analysis finds low risk of a second allergic reaction to SARS-CoV-2 mRNA vaccines in patients with an allergic reaction with the first dose.
22 Feb, 2022 | 10:05h | UTC
Commentary on Twitter
Systematic review and meta-analysis of 22 studies and 1366 patients found that there was a low risk of repeat allergic reaction to a second #COVID19 mRNA vaccine dose in people who had immediate allergic reaction with the first dose. https://t.co/NQSXBJwa6r
— JAMA Internal Medicine (@JAMAInternalMed) February 21, 2022
New practical aspects of Sweet Syndrome.
23 Feb, 2022 | 09:56h | UTCNew Practical Aspects of Sweet Syndrome – American Journal of Clinical Dermatology
UK unveils game plan for ‘living with COVID’.
22 Feb, 2022 | 09:56h | UTCUK unveils game plan for ‘living with COVID’ – CIDRAP
See also:
All you need to know about the end of Covid rules in England – The Guardian
‘Living with Covid’ strategy could do more harm than good, say businesses and unions – The Guardian
Opinion by Dr. Eric Topol | Why one-shot after a Covid-19 infection should suffice to be considered fully-vaxxed.
22 Feb, 2022 | 10:07h | UTCWhy one-shot after a Covid-19 infection should suffice to be considered fully-vaxxed – The Guardian
Commentary from the author on Twitter (thread – click for more)
My new essay @guardian
"Why one-shot after a Covid-19 infection should suffice to be considered fully-vaxxed"https://t.co/RaBUpET2CZ
Summarizes extensive new evidence that confirmed Prior Covid ("Natural Immunity" or NI) + 1-shot is as protective as 3-shots /1— Eric Topol (@EricTopol) February 20, 2022
Why does the Omicron sub-variant spread faster than the original?
22 Feb, 2022 | 09:55h | UTCWhy does the Omicron sub-variant spread faster than the original? – Nature
Related:
Covid-19: What do we know about omicron sublineages?
We regret to inform you that we are now discussing subvariants – Vox
Sudden rise of more transmissible form of Omicron catches scientists by surprise.
Omicron’s sister variant spreads faster. So why did the one we call Omicron hit first?
BA.2 is like Omicron’s sister. Here’s what we know about it so far – The Conversation
PCRRT position paper on prescribing kidney replacement therapy in critically sick children with acute liver failure.
22 Feb, 2022 | 08:48h | UTC
[Preprint] A large-scale observational study in Chile found CoronaVac (an inactivated SARS-CoV-2 vaccine) was associated with an effectiveness of 74.5% against infection, 91.0% against hospitalization, and 93.8% against ICU admission in children aged 6 to 16 years.
22 Feb, 2022 | 09:58h | UTCCommentary: Full schedule of CoronaVac vaccine shown to be highly effective in children – News Medical
Raw and cooked vegetable consumption and risk of cardiovascular disease: a study of 400,000 adults in UK Biobank.
22 Feb, 2022 | 09:51h | UTCCommentaries:
Eating veggies won’t protect your heart, study says, but critics disagree – CNN
Study Finds No Heart Benefit From Veggies. Nutritionists Disagree – HealthDay
In an observational analysis of adults (aged 18-50 years) who have undergone aortic valve surgery, the Ross procedure was associated with better outcomes compared to prosthetic aortic valve replacement.
22 Feb, 2022 | 08:44h | UTCPropensity-Matched Comparison of the Ross Procedure and Prosthetic Aortic Valve Replacement in Adults – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Position Statement: a disease state approach to the pharmacological management of type 2 diabetes in primary care.
22 Feb, 2022 | 08:51h | UTCRelated:
NICE Updated Guidance: Management of Type 2 Diabetes.
Guideline: ADA 2022 Standards of Medical Care in Diabetes.
Podcast: Tips and tricks for healing up patients with helicobacter.
22 Feb, 2022 | 08:43h | UTCPodcast: #322 H. Pylori Infection – The Curbsiders
Practice Guidance: The prevention of pressure injuries in the positioning and mobilization of patients in the ICU.
22 Feb, 2022 | 08:46h | UTC
M-A: Combining antidepressants vs. antidepressant monotherapy for treatment of patients with acute depression.
22 Feb, 2022 | 08:40h | UTCCombining Antidepressants vs Antidepressant Monotherapy for Treatment of Patients With Acute Depression: A Systematic Review and Meta-analysis – JAMA Psychiatry (free for a limited period)
M-A: Interventions to prevent spontaneous preterm birth in women with singleton pregnancy who are at high risk.
22 Feb, 2022 | 08:39h | UTC
M-A of randomized trials | Association between intensity of LDL cholesterol reduction with statin-based therapies and secondary stroke prevention.
22 Feb, 2022 | 08:37h | UTCEditorial: Low-Density Lipoprotein Cholesterol Level After a Stroke—Reducing It by Any Means (free for a limited period)